Goldman Sachs’s Covisint Corporation COVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-14,598
| Closed | -$36K | – | 7101 |
|
|
2017
Q2 | $36K | Sell |
14,598
-321
| -2% | -$670 | ﹤0.01% | 6441 |
|
|
2017
Q1 | $31K | Buy |
14,919
+81
| +0.5% | +$162 | ﹤0.01% | 6418 |
|
|
2016
Q4 | $28K | Sell |
14,838
-894
| -6% | -$1.93K | ﹤0.01% | 6558 |
|
|
2016
Q3 | $34K | Buy |
15,732
+1,494
| +10% | +$3.26K | ﹤0.01% | 6610 |
|
|
2016
Q2 | $31K | Sell |
14,238
-48
| -0.3% | -$93 | ﹤0.01% | 6587 |
|
|
2016
Q1 | $29K | Sell |
14,286
-3,840
| -21% | -$7.79K | ﹤0.01% | 6628 |
|
|
2015
Q4 | $45K | Sell |
18,126
-34,392
| -65% | -$77.9K | ﹤0.01% | 6594 |
|
|
2015
Q3 | $113K | Sell |
52,518
-150,972
| -74% | -$415K | ﹤0.01% | 6414 |
|
|
2015
Q2 | $665K | Buy |
203,490
+125,332
| +160% | +$297K | ﹤0.01% | 4898 |
|
|
2015
Q1 | $159K | Sell |
78,158
-170,059
| -69% | -$397K | ﹤0.01% | 6163 |
|
|
2014
Q4 | $658K | Buy |
+248,217
| New | +$711K | ﹤0.01% | 5016 |
|
Goldman Sachs's COVS Position: Q3 2017 in Review
Goldman Sachs sold out of Covisint Corporation (COVS) in Q3 2017, closing a stake of 14,598 shares — an estimated $36K sold.
Goldman Sachs first reported a position in COVS in Q4 2014 and held it in 11 quarters. The position peaked at $665K in Q2 2015. 0 funds tracked by Wall St. Rank hold COVS as of Q3 2017.
- Goldman Sachs reported no remaining Covisint Corporation position as of Q3 2017 after selling out during the quarter.
- Goldman Sachs sold 14,598 Covisint Corporation shares in Q3 2017, an estimated $36K.
- Goldman Sachs first reported a position in Covisint Corporation in Q4 2014 and held it in 11 quarters.
- Goldman Sachs's Covisint Corporation position peaked at $665K in Q2 2015.
- 0 funds tracked by Wall St. Rank held Covisint Corporation as of Q3 2017.
Based on Goldman Sachs's 13F filing for Q3 2017, filed 14 Nov 2017.